Influence of dysbiotic syndrome on the formation of experimental nepropathy
DOI:
https://doi.org/10.12775/JEHS.2024.53.022Keywords
Dysbiosis, nephropathy, systemic inflammatory response syndrome, pro- and antioxidant system, pathogenesis, microbiota, kidneyAbstract
Kidneys are sensitive to damage by pathogenic factors of dysbiotic syndrome, among which lipopolysaccharide is the main one. However, the influence of the dysbiotic syndrome on the formation of nephropathy has not been studied enough.
The aim of the study is to determine the effect on the kidneys of rats of an experimental dysbiotic syndrome, which was modeled using the antibiotic lincomycin in combination with the administration of epinephrine.
Material and methods. Experimental dysbiotic syndrome (systemic dysbiosis) was reproduced in 21 Wistar rats (female, 11 months old, average weight 310±25 g) by administration of lincomycin with adrenaline hydrotartrate. The activity of urease and lysozyme was determined in blood serum and tissue homogenates and the degree of dysbiosis was calculated. The condition of the kidneys was assessed by the activity of elastase, urease, lysozyme, catalase, the content of malondialdehyde (MDA), creatinine, indicators of antioxidant protection.
Results. The level of urease increases in the liver of rats with experimental dysbiosis by 2.3 times, in the mucous membrane of the stomach - by two times, and in blood serum - by 2.3 times. The activity of lysozyme decreases in rats with dysbiosis: in the liver - by 42%, in the stomach - by 36%, and in blood serum - by 32%. Urease activity in the kidneys increases by 76%, lysozyme activity decreases by 33%, which indicates a 2.6-fold increase in the degree of dysbiosis. As a result of dysbiosis in the kidneys, the level of biochemical markers of inflammation significantly increases: elastase by 79.5% and MDA by 18%, catalase activity significantly decreases (by 6%).
Conclusions. The combined administration of lincomycin and adrenaline causes the development of a dysbiotic syndrome in experimental animals. Under the condition of modeling the dysbiotic syndrome, an inflammatory-dystrophic process develops in the kidneys, and the level of antioxidant protection significantly decreases. Under conditions of experimental dysbiosis, pathological processes in the kidneys are manifested to a lesser extent than in other organs, possibly due to the high initial level of lysozyme in the tissue.
References
Lobel L, Cao YG, Fenn K, Glickman JN, Garrett WS. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science. 2020;369:1518–24. 10.1126/science.abb3763.
Cao C, Zhu H, Yao Y, Zeng R. Gut Dysbiosis and Kidney Diseases. Front Med (Lausanne). 2022 Mar 3;9:829349. doi: 10.3389/fmed.2022.829349.
Polovyi VP, Popadyuk OY, Sydorchuk RI, Shelefontiuk IV, Sydorchuk LI. Preclinical evaluation of the individualized approach for chronic non-healing wounds management. General Surgery. 2024;2(9):54-58.
Tartaglia, D., Cremonini, C., Annunziata, E. et al. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T). Tech Coloproctol. 2023. https://doi.org/10.1007/s10151-023-02758-6.
Hess, B., Cahenzli, M., Forbes, A., WFICC (World Federation of Intensive and Critical Care). Management of acute mesenteric ischaemia: Results of a worldwide survey. Clinical Nutrition ESPEN. 2023;54: 194–205. https://doi.org/10.1016/j.clnesp.2022.12.022.
De Simone, Abu-Zidan B, Chouillard FME, et al. The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis? World J Emerg Surg. 2022;17:61. https://doi.org/10.1186/s13017-022-00466-4.
Polyovyy VP, Sydorchuk RI, Fedonyuk LY, Rotar OV, Polyovyy PV, Chepega IG, Fomin AA. Application of antibiotics and probiotics for prevention of antibiotic-associated disbiosis in patients with generalized peritonitis and enteral dysfunction supports staff awareness. Wiad Lek. 2021;74(3 cz 1):508-511.
Prysyazhnyuk V, Sydorchuk L, Sydorchuk R, Prysiazhniuk I, Bobkovych K, Buzdugan I, Dzuryak V, Prysyazhnyuk P. Glutathione-S-transferases genes-promising predictors of hepatic dysfunction. World J Hepatol. 2021;13(6):620-633 [DOI: 10.4254/wjh.v13.i6.620].
Sydorchuk L, Dzhuryak V, Sydorchuk A, Levytska S, Petrynych V, Knut R, Kshanovska A, Iftoda A, Tkachuk O, Kyfiak P, Popovich A, Khomko O, Sydorchuk R. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients. Endocrine Regulations. 2020;54(3):217-226. doi:10.2478/enr-2020-0024.
Dzhuryak V, Sydorchuk L, Sydorchuk A, Kamyshnyi O, Kshanovska A, Levytska S, Knut R, Sheremet M, Ivashchuk S, Petrynych O, Kazantseva T, Nikyfor L, Melnychuk L, Sokolenko A, Yarynych Y, Semianiv M, Rep-chuk Y, Voroniuk K, Sydorchuk R, Sokolenko L, Iftoda O, Kushnir O. The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients. Biointerface Research in Applied Chemistry. 2020;10(3):5406-5411. https://doi.org/10.33263/BRIAC103.406411.
Tecklenborg J, Clayton D, Siebert S, Coley SM. The role of the immune system in kidney disease. Clin Exp Immunol. 2018;192:142–50. 10.1111/cei.13119.
Tomas-Simo P, D'Marco L, Romero-Parra M, Tormos-Muñoz MC, Sáez G, Torregrosa I, et al. Oxidative stress in non-dialysis-dependent chronic kidney disease patients. Int J Environ Res Public Health. 2021;18:7806. 10.3390/ijerph18157806.
Knauf F, Brewer JR, Flavell RA. Immunity, microbiota and kidney disease. Nat Rev Nephrol. 2019;15:263–74. 10.1038/s41581-019-0118-7.
Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet. Microorganisms. 2020;8:1862. 10.3390/microorganisms8121862.
Anders HJ. 2019 Update in basic kidney research: microbiota in chronic kidney disease, controlling autoimmunity, kidney inflammation and modelling the glomerular filtration barrier. Nephrol Dial Transplant. 2020;35:4–9. 10.1093/ndt/gfz219.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 V. Stepan, R. Sydorchuk, N. Stepan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 42
Number of citations: 0